Cost-Effectiveness of Lung Volume Reduction Surgery

Completed · Phase 2

Conditions studied: Chronic Obstructive Pulmonary Disease, Emphysema

In brief

Lung volume reduction surgery (LVRS) has been advanced as a therapy to significantly improve quality of life in patients with COPD, but to date no controlled studies have evaluated the impact of LVRS.

Key facts

Study ID

NCT00013156

Run by

US Department of Veterans Affairs

People needed

92

Expected to finish

2000-03-01

Last updated by the study team

2015-04-07

Who can join

Age: any, up to 75. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Severe COPD as defined by FEV1 of 20-30% predicted; marked hyperinflation with a residual volume of >165% predicted; 6-min walk greater than 600 ft; abstinence from cigarette smoking for 3-mths; absence of co-morbid illnesses that would significantly increase surgical risk, such as severe coronary artery disease

Where it is running

• VA Puget Sound Health Care System Seattle Division, Seattle, WA — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.